EU External Trade - Other, Aminorex (INN), brotizolam (INN), clotiazepam (INN), cloxazolam (INN), dextromoramide (INN), haloxazolam (INN), ketazolam (INN), mesocarb (INN), oxazolam (INN), pemoline (INN), phendimetrazine (INN), phenmetrazine (INN) and sufentanil (INN); salts thereof

Extra-EU sourcing of Other, Aminorex (INN), brotizolam (INN), clotiazepam (INN), cloxazolam (INN), dextromoramide (INN), haloxazolam (INN), ketazolam (INN), mesocarb (INN), oxazolam (INN), pemoline (INN), phendimetrazine (INN), phenmetrazine (INN) and sufentanil (INN); salts thereof is highly concentrated. 🇮🇱 Israel captures 37.7% of imports (€5.8M), followed by 🇮🇳 India (33.3%). With an HHI of 2802, this Concentrated market exposes the EU to supply dependency risks.

European exports of Other, Aminorex (INN), brotizolam (INN), clotiazepam (INN), cloxazolam (INN), dextromoramide (INN), haloxazolam (INN), ketazolam (INN), mesocarb (INN), oxazolam (INN), pemoline (INN), phendimetrazine (INN), phenmetrazine (INN) and sufentanil (INN); salts thereof are concentrated on a few markets. 🇯🇵 Japan accounts for 66.4% (€25.5M), ahead of 🇽🇸 XS (12.2%). The top three destinations are 🇯🇵 Japan, 🇽🇸 XS, 🇮🇱 Israel.

Within the EU, the leading importers of Other, Aminorex (INN), brotizolam (INN), clotiazepam (INN), cloxazolam (INN), dextromoramide (INN), haloxazolam (INN), ketazolam (INN), mesocarb (INN), oxazolam (INN), pemoline (INN), phendimetrazine (INN), phenmetrazine (INN) and sufentanil (INN); salts thereof are 🇳🇱 Netherlands, 🇫🇷 France, 🇩🇰 Denmark. 🇳🇱 Netherlands accounts for 37.8% of EU imports.

In 2025, trade flows diverged: imports were rising (6.3%) while exports were falling sharply (-46.6%), signalling a structural market shift.